Characterization of Mycobacterium smegmatis mutants defective in 1-D-myo-inosityl-2-amino-2-deoxy-α-D-glucopyranoside and mycothiol biosynthesis

被引:82
作者
Newton, GL
Unson, MD
Anderberg, SJ
Aguilera, JA
Oh, NN
delCardayre, SB
Av-Gay, Y
Fahey, RC [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V5Z 3J5, Canada
关键词
D O I
10.1006/bbrc.1999.0156
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycothiol (MSH) is the major low molecular weight thiol in mycobacteria, Two chemical mutants with low MSH and one with no MSH (strain 49) were produced in Mycobacterium smegmatis mc(2)155 to assess the role of MSH in mycobacteria. Strain 49 was shown to not produce 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside (GlcN-Ins), an intermediate in MSH biosynthesis. Relative to the parent strain, mutant 49 formed colonies more slowly on solid media and was more sensitive to H2O2 and rifampin, but less sensitive to isoniazid. Complementation of mutant 49 with DNA from M. tuberculosis H37Rv partially restored production of GlcN-Ins and MSH, and resistance to H2O2, but largely restored colony growth rate and sensitivity to rifampin and isoniazid, The results indicate that MSH and GlcN-Ins are not essential for in vitro survival of mycobacteria but may play significant roles in determining the sensitivity of mycobacteria to environmental toxins. (C) 1999 Academic Press.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 29 条
[1]   Mycothiol biosynthesis and metabolism -: Cellular levels of potential intermediates in the biosynthesis and degradation of mycothiol in Mycobacterium smegmatis [J].
Anderberg, SJ ;
Newton, GL ;
Fahey, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30391-30397
[2]   ISOLATION AND INITIAL CHARACTERIZATION OF GLUTATHIONE-DEFICIENT MUTANTS OF ESCHERICHIA-COLI K-12 [J].
APONTOWEIL, P ;
BERENDS, W .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 399 (01) :10-22
[3]   Molecular mechanisms of drug resistance in Mycobacterium tuberculosis [J].
Blanchard, JS .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :215-239
[4]   Biosynthesis of mycothiol: elucidation of the sequence of steps in Mycobacterium smegmatis [J].
Bornemann, C ;
Jardine, MA ;
Spies, HSC ;
Steenkamp, DJ .
BIOCHEMICAL JOURNAL, 1997, 325 :623-629
[5]   Molecular action of anti-mycobacterial agents [J].
Chopra, I ;
Brennan, P .
TUBERCLE AND LUNG DISEASE, 1998, 78 (02) :89-98
[6]  
CONNELL ND, 1994, METHOD CELL BIOL, V45, P107
[7]   RIBOSYLATION BY MYCOBACTERIAL STRAINS AS A NEW MECHANISM OF RIFAMPIN INACTIVATION [J].
DABBS, ER ;
YAZAWA, K ;
MIKAMI, Y ;
MIYAJI, M ;
MORISAKI, N ;
IWASAKI, S ;
FURIHATA, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :1007-1009
[8]  
FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1
[9]   SPECIFIC INHIBITION OF DNA-DIRECTED RNA SYNTHESIS BY RIFAMYCIN [J].
HARTMANN, G ;
HONIKEL, KO ;
KNUSEL, F ;
NUESCH, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 145 (03) :843-&
[10]   PERMEABILITY BARRIER TO RIFAMPIN IN MYCOBACTERIA [J].
HUI, J ;
GORDON, N ;
KAJIOKA, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (05) :773-779